Sabrina N Grondhuis1, Cristan A Farmer2, L Eugene Arnold3, Kenneth D Gadow4, Robert L Findling5, Brooke S G Molina6, David J Kolko6, Kristin A Buchan-Page7, Robert R Rice7, Eric M Butter7,8, Michael G Aman7. 1. Department of Psychology and Neuroscience, Millsaps College, Jackson, Mississippi. 2. Intermural Research Program, Department of Pediatrics and Developmental Neuroscience Branch, National Institutes of Health, Bethesda, Maryland. 3. Department of Psychiatry, The Ohio State University, Columbus, Ohio. 4. Department of Psychiatry, State University of New York, Stony Brook, New York. 5. Division of Child & Adolescent Psychiatry, Bloomberg Children's Center, Baltimore, Maryland. 6. Department of Psychiatry & Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania. 7. Nisonger Center, The Ohio State University, Columbus, Ohio. 8. Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.
Abstract
Objective: To explore blinded observational outcomes in the Treatment of Severe Childhood Aggression (TOSCA) study. Methods: During a 9-week acute trial, children with severe physical aggression and attention-deficit/hyperactivity disorder received parent training + titrated psychostimulant for 3 weeks, and those who failed to show an optimal response during Week 4 through Week 6 received in addition either randomly assigned placebo (Basic treatment) or titrated risperidone (Augmented treatment). Child and parent behaviors were videotaped in a Standardized Observation Analogue Procedure (SOAP) designed to elicit problems and strengths in child and parent interactions. SOAPs were collected at baseline and Week 9 and 52 follow-up. Results: During the acute 9-week trial, augmented treatment was associated with better outcomes than basic treatment for 3 of 13 measures: increased Child Compliance (p = 0.004; significant after correction for multiple tests), greater use of positive Parent Reinforcement (p = 0.03), and more Shared Enjoyment (p = 0.04). At follow-up, when medication was no longer by randomized assignment, parents used more Alpha Commands and displayed fewer Parent Negative Behaviors, and the dyads showed more Shared Enjoyment regardless of original randomization. Thus, there were better parent-child interactions with Augmented treatment, and interactions improved overall at follow-up regardless of original treatment assignment. Conclusions: The SOAP demonstrated sensitivity to behavior changes between short-term treatments for a few (but not most) measures. The acute treatment differences for Child Compliance and Child Negative Behavior are generally consistent with the moderate superiority of Augmented over Basic treatment previously reported for the primary study outcome.
RCT Entities:
Objective: To explore blinded observational outcomes in the Treatment of Severe Childhood Aggression (TOSCA) study. Methods: During a 9-week acute trial, children with severe physical aggression and attention-deficit/hyperactivity disorder received parent training + titrated psychostimulant for 3 weeks, and those who failed to show an optimal response during Week 4 through Week 6 received in addition either randomly assigned placebo (Basic treatment) or titrated risperidone (Augmented treatment). Child and parent behaviors were videotaped in a Standardized Observation Analogue Procedure (SOAP) designed to elicit problems and strengths in child and parent interactions. SOAPs were collected at baseline and Week 9 and 52 follow-up. Results: During the acute 9-week trial, augmented treatment was associated with better outcomes than basic treatment for 3 of 13 measures: increased Child Compliance (p = 0.004; significant after correction for multiple tests), greater use of positive Parent Reinforcement (p = 0.03), and more Shared Enjoyment (p = 0.04). At follow-up, when medication was no longer by randomized assignment, parents used more Alpha Commands and displayed fewer Parent Negative Behaviors, and the dyads showed more Shared Enjoyment regardless of original randomization. Thus, there were better parent-child interactions with Augmented treatment, and interactions improved overall at follow-up regardless of original treatment assignment. Conclusions: The SOAP demonstrated sensitivity to behavior changes between short-term treatments for a few (but not most) measures. The acute treatment differences for Child Compliance and Child Negative Behavior are generally consistent with the moderate superiority of Augmented over Basic treatment previously reported for the primary study outcome.
Authors: Robert L Findling; Lisa Townsend; Nicole V Brown; L Eugene Arnold; Kenneth D Gadow; David J Kolko; Nora K McNamara; Devin S Gary; Dana B Kaplin; Cristan A Farmer; Heidi Kipp; Craig Williams; Eric M Butter; Oscar G Bukstein; Robert Rice; Kristin Buchan-Page; Brooke S G Molina; Michael G Aman Journal: J Child Adolesc Psychopharmacol Date: 2017-02 Impact factor: 2.576
Authors: Karen C Wells; Terry C Chi; Stephen P Hinshaw; Jeffery N Epstein; Linda Pfiffner; Marie Nebel-Schwalm; Elizabeth B Owens; L Eugene Arnold; Howard B Abikoff; C Keith Conners; Glen R Elliott; Laurence L Greenhill; Lily Hechtman; Betsy Hoza; Peter S Jensen; John March; Jeffrey H Newcorn; William E Pelham; Joanne B Severe; James Swanson; Benedetto Vitiello; Timothy Wigal Journal: J Consult Clin Psychol Date: 2006-08
Authors: Kenneth D Gadow; Nicole V Brown; L Eugene Arnold; Kristin A Buchan-Page; Oscar G Bukstein; Eric Butter; Cristan A Farmer; Robert L Findling; David J Kolko; Brooke S G Molina; Robert R Rice; Jayne Schneider; Michael G Aman Journal: J Am Acad Child Adolesc Psychiatry Date: 2016-04-13 Impact factor: 8.829
Authors: L Eugene Arnold; Shirley Chuang; Mark Davies; Howard B Abikoff; C Keith Conners; Glen R Elliott; Laurence L Greenhill; Lily Hechtman; Stephen P Hinshaw; Betsy Hoza; Peter S Jensen; Helena C Kraemer; Kristen S Langworthy-Lam; John S March; Jeffrey H Newcorn; William E Pelham; Joanne B Severe; James M Swanson; Benedetto Vitiello; Karen C Wells; Timothy Wigal Journal: J Abnorm Child Psychol Date: 2004-02
Authors: Michael G Aman; Oscar G Bukstein; Kenneth D Gadow; L Eugene Arnold; Brooke S G Molina; Nora K McNamara; E Victoria Rundberg-Rivera; Xiaobai Li; Heidi Kipp; Jayne Schneider; Eric M Butter; Jennifer Baker; Joyce Sprafkin; Robert R Rice; Srihari S Bangalore; Cristan A Farmer; Adrienne B Austin; Kristin A Buchan-Page; Nicole V Brown; Elizabeth A Hurt; Sabrina N Grondhuis; Robert L Findling Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-11-18 Impact factor: 8.829
Authors: Benjamin L Handen; Cynthia R Johnson; Eric M Butter; Luc Lecavalier; Lawrence Scahill; Michael G Aman; Christopher J McDougle; L Eugene Arnold; Naomi B Swiezy; Denis G Sukhodolsky; James A Mulick; Susan W White; Karen Bearss; Jill A Hollway; Kimberly A Stigler; James Dziura; Sunkyung Yu; Kelley Sacco; Benedetto Vitiello Journal: J Dev Phys Disabil Date: 2013-06-01
Authors: Cynthia R Johnson; Eric M Butter; Benjamin L Handen; Denis G Sukhodolsky; James Mulick; Luc Lecavalier; Michael G Aman; L Eugene Arnold; Lawrence Scahill; Naomi Swiezy; Kelley Sacco; Kimberly A Stigler; Christopher J McDougle Journal: J Intellect Dev Disabil Date: 2009-09